Screening tool digs deeper into opioid risk assessment | Addiction Professional Magazine Skip to content Skip to navigation

Screening tool digs deeper into opioid risk assessment

September 26, 2017
by Gary A. Enos, Editor
| Reprints

A university research center and a national justice services organization have created a screening tool designed to improve assessment of opioid overdose risk and addiction treatment need.

The TCU Drug Screen 5 - Opioid Supplement is available to addiction treatment and criminal justice professionals. Developed by researchers at Texas Christian University's Institute of Behavioral Research and the Center for Health and Justice at TASC (Treatment Alternatives for Safe Communities), the 17-question screening instrument includes specific questions about individuals' frequency, purpose and methods of opioid use. This is designed to inform more rapid and more accurate judgments about treatment referral.

“With so many professions now on the front lines of fighting the opioid epidemic, people are looking for tools to help them earlier and faster in their decision making,” Jac Charlier, national director for justice initiatives at the Center for Health and Justice, said in a Sept. 22 news release.

The tool is also designed to help professionals determine if an individual could benefit from having immediate access to the opioid overdose reversal drug naloxone.

The instrument is a supplement to the existing TCU Drug Screen 5, which screens for mild to severe substance use disorders. More information about the instrument is available by e-mailing Kevin Knight, deputy director of TCU's Institute of Behavioral Research, at ibr@tcu.edu.

 

 

Get the latest information on Prescription Drug Abuse and other valuable topics at the summit where solutions are formulated, stakeholders convene, and change begins on addressing the opioid crisis.

Learn More

Topics